The initial success of Viagra undeniably reshaped the drug landscape, but investing in companies heavily reliant on off-patent versions presents a uncertain picture. While early profits were substantial, the expiration of patents and the emergence of less expensive alternatives have weakened the customer base. Consequently, a thorough analysis o… Read More